Airbus SE (BIT:1AIR)

Market Cap	143.11B
Revenue (ttm)	70.02B
Net Income (ttm)	4.93B
Shares Out	n/a
EPS (ttm)	6.24
PE Ratio	29.02
Forward PE	25.21
Dividend	3.00 (1.70%)
Ex-Dividend Date	Apr 22, 2025

Volume	1,729
Average Volume	1,464
Open	176.64
Previous Close	177.64
Day's Range	176.26 - 178.82
52-Week Range	125.28 - 187.00
Beta	1.25
RSI	58.29
Earnings Date	Jul 30, 2025

About Marinus Pharmaceuticals

Airbus SE, together with its subsidiaries, engages in the design, manufacture, and delivery of aeronautics and aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft, freighter aircraft, regional turboprop aircraft, and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment develops, manufactures, m...

• Industry: Aerospace & Defense
• Sector: Industrials
• Founded: 1998
• Employees: 156,921
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1AIR

Financial Performance

In 2024, Airbus SE's revenue was 69.23 billion, an increase of 5.78% compared to the previous year's 65.45 billion. Earnings were 4.23 billion, an increase of 11.69%.